Abbott Laboratories Company Insiders

ABT Stock  USD 126.34  0.44  0.35%   
Abbott Laboratories employs about 114 K people. The company is managed by 49 executives with a total tenure of roughly 363 years, averaging almost 7.0 years of service per executive, having 2326.53 employees per reported executive. Breaking down Abbott Laboratories' management performance can provide insight into the firm performance.
Robert Ford  CEO
President, Chief Executive Officer, Chief Operating Officer, Director
Miles White  Chairman
Chairman, CEO and Chairman of Executive Committee
  
Check out Trending Equities to better understand how to build diversified portfolios, which includes a position in Abbott Laboratories. Also, note that the market value of any company could be closely tied with the direction of predictive economic indicators such as signals in bureau of labor statistics.
For more information on how to buy Abbott Stock please use our How to Invest in Abbott Laboratories guide.

Abbott Laboratories' latest congressional trading

Congressional trading in companies like Abbott Laboratories, is subject to rigorous scrutiny to prevent conflicts of interest and insider trading. This is governed by multiple SEC regulations which were established to foster transparency and deter members of Congress from leveraging non-public information for personal gain. This oversight helps maintain public trust and ensures that investments in Abbott Laboratories by those in governmental positions are based on the same information available to the general public.
2025-03-07Representative Josh GottheimerAcquired Under $15KVerify
2025-03-05Senator Shelley Moore CapitoAcquired Under $15KVerify
2025-02-12Representative Emily RandallAcquired Under $15KVerify
2025-02-11Representative Jared MoskowitzAcquired Under $15KVerify
2025-01-30Senator Markwayne MullinAcquired Under $15KVerify
2025-01-23Representative Thomas H KeanAcquired Under $15KVerify
2024-12-30Senator Markwayne MullinAcquired $15K to $50KVerify
2024-12-18Representative Michael McCaulAcquired $50K to $100KVerify
2024-09-18Representative Michael McCaulAcquired $50K to $100KVerify
2024-09-11Representative Josh GottheimerAcquired Under $15KVerify
2024-09-02Representative John JamesAcquired Under $15KVerify
2024-08-21Representative Jared MoskowitzAcquired Under $15KVerify
2024-08-19Representative Jared MoskowitzAcquired Under $15KVerify
2024-08-16Representative Kathy ManningAcquired Under $15KVerify
2024-08-15Representative Josh GottheimerAcquired Under $15KVerify
2024-02-01Senator Thomas R CarperAcquired Under $15KVerify
2023-10-31Senator Markwayne MullinAcquired Under $15KVerify
2023-10-20Senator Pete RickettsAcquired $100K to $250KVerify
2023-10-11Senator Markwayne MullinAcquired $15K to $50KVerify
2022-11-03Senator Thomas R CarperAcquired Under $15KVerify
2022-10-12Representative David B McKinleyAcquired Under $15KVerify
2022-08-13Representative Dean PhillipsAcquired Under $15KVerify
2022-05-13Representative Robert J WittmanAcquired Under $15KVerify
2022-01-27Representative Michael C BurgessAcquired Under $15KVerify
2019-04-24Senator Tina SmithAcquired $250K to $500KVerify
2018-05-05Representative Pete SessionsAcquired Under $15KVerify
2017-11-07Senator Tammy DuckworthAcquired Under $15KVerify
2015-08-03Senator Shelley Moore CapitoAcquired Under $15KVerify

Abbott Laboratories Management Team Effectiveness

The company has Return on Asset of 0.0606 % which means that on every $100 spent on assets, it made $0.0606 of profit. This is way below average. In the same way, it shows a return on shareholders' equity (ROE) of 0.3091 %, implying that it generated $0.3091 on every 100 dollars invested. Abbott Laboratories' management efficiency ratios could be used to measure how well Abbott Laboratories manages its routine affairs as well as how well it operates its assets and liabilities.

Abbott Laboratories Workforce Comparison

Abbott Laboratories is rated second in number of employees category among its peers. The total workforce of Health Care industry is presently estimated at about 483,200. Abbott Laboratories totals roughly 114,000 in number of employees claiming about 24% of equities under Health Care industry.
The company has Net Profit Margin of 0.32 %, which implies that it may need a different competitive strategy as even a very small decline in it revenue may erase profits and result in a net loss. This is way below average. In the same way, it shows Net Operating Margin of 0.19 %, which entails that for every 100 dollars of revenue, it generated $0.19 of operating income.

Abbott Laboratories Insider Trading

Some recent studies suggest that insider trading raises the cost of capital for securities issuers and decreases overall economic growth. Trading by specific Abbott Laboratories insiders, such as employees or executives, is commonly permitted as long as it does not rely on Abbott Laboratories' material information that is not in the public domain. Local jurisdictions usually require such trading to be reported in order to monitor insider transactions. In many U.S. states, trading conducted by corporate officers, key employees, directors, or significant shareholders must be reported to the regulator or publicly disclosed, usually within a few business days of the trade. In these cases, Abbott Laboratories insiders must file a Form 4 with the U.S. Securities and Exchange Commission (SEC) when buying or selling shares of their own companies.

Abbott Laboratories Notable Stakeholders

An Abbott Laboratories stakeholder refers to an individual interested in an outcome of the business. Different stakeholders have different interests, and companies such as Abbott Laboratories often face trade-offs trying to please all of them. Abbott Laboratories' stakeholders can have a positive or negative influence on the entity's direction, and there are a lot of executives involved in getting Abbott Laboratories' stock to the level that pleases all shareholders. Keeping track of the stakeholders is a great way to stay on top of things affecting its ongoing price.
Robert FordPresident, Chief Executive Officer, Chief Operating Officer, DirectorProfile
Miles WhiteChairman, CEO and Chairman of Executive CommitteeProfile
Roger BirdSenior Vice President - U.S. NutritionProfile
Hubert AllenExecutive Vice President, General Counsel, SecretaryProfile
Jared WatkinSenior Vice President - Diabetes CareProfile
Jaime ContrerasSenior Vice President - Core Laboratory Diagnostics, Commercial OperationsProfile
Andrew LaneSenior Vice President - Established Pharmaceuticals, Emerging MarketsProfile
John CapekExecutive Vice President - VenturesProfile
Joseph ManningSenior Vice President - Abbott Nutrition InternationalProfile
Robert FunckChief Financial Officer, Executive Vice President - FinanceProfile
Daniel SalvadoriSenior Vice President - Established Pharmaceuticals, Latin America.Profile
Samuel ScottIndependent DirectorProfile
Phebe NovakovicIndependent DirectorProfile
Roxanne AustinIndependent DirectorProfile
Sally BlountIndependent DirectorProfile
Daniel StarksIndependent DirectorProfile
Robert AlpernIndependent DirectorProfile
Glenn TiltonIndependent DirectorProfile
Darren McDewIndependent DirectorProfile
Patricia GonzalezIndependent DirectorProfile
Nancy McKinstryIndependent DirectorProfile
Michelle KumbierIndependent DirectorProfile
Edward LiddyIndependent DirectorProfile
John StrattonIndependent DirectorProfile
William OsbornLead Independent DirectorProfile
Hubert JDGeneral VPProfile
Erica BattagliaVP OfficerProfile
Christopher ScogginsSenior Vice President - Rapid DiagnosticsProfile
Michael DaleSenior Vice President - Structural HeartProfile
Sammy KaramSenior Vice President - Established Pharmaceuticals, Emerging MarketsProfile
Michael PedersonSenior Vice President - Electrophysiology and Heart FailureProfile
Lisa EarnhardtExecutive Vice President - Medical DevicesProfile
Alejandro WellischSenior Vice President - Established Pharmaceuticals, Latin AmericaProfile
Christopher CalamariSenior Vice President - U.S. NutritionProfile
Charles BrynelsenSenior Vice President - Abbott VascularProfile
Gregory AhlbergSenior Vice President - Core Laboratory Diagnostics, Commercial OperationsProfile
Philip BoudreauVice President - Finance, ControllerProfile
John GinascolExecutive Vice President - Core DiagnosticsProfile
Michael RomanIndependent DirectorProfile
Mary MorelandExecutive Vice President of Human ResourcesProfile
Sabina EwingSenior OfficerProfile
Randel WoodgriftSenior Vice President - CRMProfile
Elaine LeavenworthVP OfficerProfile
Michael ComillaVice RelationsProfile
Scott LeinenweberAcquisitions LicensingProfile
James YoungVP OfficerProfile
Louis MorroneSenior Vice President - Rapid DiagnosticsProfile
Andrea WainerExecutive Vice President - Rapid and Molecular DiagnosticsProfile
Melissa BrotzVice MarketingProfile

About Abbott Laboratories Management Performance

The success or failure of an entity such as Abbott Laboratories often depends on how effective the management is. Abbott Laboratories management team is responsible for propelling the future growth in the right direction and administering and controlling the business activities and accounting for the results. Ineffective management usually contributes to failure in the company's future performance for all stakeholders equally, but most importantly, for investors. So it is important to measure the effectiveness of Abbott management before purchasing its stock. In many ways, it's all about finding the answer to one important question - Are they doing the right thing right now? How would we assess whether the Abbott management is utilizing all available resources in the best possible way? Also, how well is the company doing relative to others in its sector and the market as a whole? The answer can be found by analyzing a few important fundamental indicators such as return on assets and return on equity.
Abbott Laboratories, together with its subsidiaries, discovers, develops, manufactures, and sells health care products worldwide. Abbott Laboratories was founded in 1888 and is based in North Chicago, Illinois. Abbott Laboratories operates under Medical Devices classification in the United States and is traded on New York Stock Exchange. It employs 113000 people.
Please note, the imprecision that can be found in Abbott Laboratories' accounting process means that the reasonable investor should take a skeptical approach toward the financial statement analysis of Abbott Laboratories. Check Abbott Laboratories' Beneish M Score to see the likelihood of Abbott Laboratories' management manipulating its earnings.

Abbott Laboratories Workforce Analysis

Traditionally, organizations such as Abbott Laboratories use manpower efficiency calculations for various incentive schemes, employee appraisal, or as an initiative to improve the processes. However, it can also be used by investors to make long-term investment decisions. The trends in the profit per employee or revenue per employee are measured by net income or revenue divided by the current number of full-time employees over a given time interval. Because workforce needs differ across sectors, these ratios could be used to compare Abbott Laboratories within its industry.

Abbott Laboratories Manpower Efficiency

Return on Abbott Laboratories Manpower

Revenue Per Employee368K
Revenue Per Executive856.1M
Net Income Per Employee117.6K
Net Income Per Executive273.5M
Working Capital Per Employee83.3K
Working Capital Per Executive193.9M

Additional Tools for Abbott Stock Analysis

When running Abbott Laboratories' price analysis, check to measure Abbott Laboratories' market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Abbott Laboratories is operating at the current time. Most of Abbott Laboratories' value examination focuses on studying past and present price action to predict the probability of Abbott Laboratories' future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Abbott Laboratories' price. Additionally, you may evaluate how the addition of Abbott Laboratories to your portfolios can decrease your overall portfolio volatility.